Delivery Order SPE2DB22D9207-SPE2DB24FH4UH
Award Date 11/17/23
Potential Completion Date 12/11/23
Potential Value $5.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Omidria 1-0.3% vials. The $9,205.68 order calls for the delivery of the pharmaceutical item to a facility located in Park Ridge, Illinois, with work to be completed by December 18, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency not to exceed $5 million to supply various...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,174.74 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025, for the supply of Omidria 1-0.3% vials (4ML). This delivery order is issued under the company's larger single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency's pharmaceutical prime vendor contract for $1,150.71 to supply one unit of OMIDRIA 1-0.3% vial containing 4 mL to Defense Logistics Agency Troop Support Medical. Performance will occur in Park Ridge, Illinois through December 2023. As the prime vendor, DMS Pharmaceutical Group maintains indefinite delivery contracts with the Defense Logistics Agency to provide pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide Omidria 1-0.3% vials. The $4,602.84 order calls for delivery of the specified pharmaceutical item to a facility located in Park Ridge, Illinois by May 23, 2023. DMS Pharmaceutical Group will supply the product from its location in Park Ridge. No set-aside designation was applied to this order issued under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,174.74 on August 4, 2025, for the supply of OMIDRIA 1-0.3% vials (4ml). This firm fixed-price delivery order, issued without a set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and carries an ultimate completion date of August 25, 2025. The award represents a continuation of DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,174.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4mL). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating the contractor competed in an unrestricted procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,881.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% Vial 4ML. This firm fixed-price delivery order, issued on November 28, 2025, with an ultimate completion date of December 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a $2,391.60 delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for Omidria 1-0.3% vial 4ML, a pharmaceutical product used during ophthalmic surgery. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,737.97, is for the delivery of OMIDRIA 1-0.3% vial, 4 mL, a pharmaceutical product. The contract has a firm fixed price and no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4 mL) with a contract value of $2,391.60. This firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 26, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...